Medicare Compliance & Reimbursement
Enzi Treads Cautiously On Rx Importation
Sen. Mike Enzi (R-WY) said April 19 that his Health, Education, Labor, and Pensions Committee would move forward on legislation allowing the importation of less-expensive prescription drugs into the United States without the manufacturer's consent.
"We will do something on drug importation," Enzi said at a HELP hearing on S 334 importation legislation.
Enzi has made no secret of his fears that allowing drug importation could expose Americans to counterfeit drugs and jeopardize pharmaceutical innovation by essentially importing foreign price controls. But he has also acknowledged that importation proponents have the 60 Senate votes necessary to break a filibuster.
To ensure that he has a hand in shaping legislation, Enzi co-sponsored a successful amendment to the Senate budget resolution creating a reserve fund for an importation bill that comes out of HELP. At the hearing, Enzi emphasized the need to move cautiously, and asked if hearing co-sponsor Byron Dorgan (D-ND) was interested in reviving the Prairie Prescriptions Pilot Project, a proposal Dorgan made last spring to former HHS Secretary Tommy Thompson to allow North Dakota to host a two-year importation demonstration program.
Noting that other states have made similar requests, Enzi said starting importation with state demos before going national would allow problems to be spotted and resolved in local laboratories.
Dorgan responded that he proposed a demonstration project "only because we were unable to make any progress with the administration on a broader approach," and he noted pointedly that "we're still waiting for a response" on the Prairie Prescriptions proposal.
Medicare Compliance & Reimbursement
- HIPAA:
Providers Should Target PHI Mishaps For Extinction
Minor slip-ups can evolve into major legal issues.
An employee's honest mistake can expose a patient's [...] - REHAB:
Meeting IRF Criteria A Must For Facilities
Compliance review periods governed by tricky CMS guidelines.
Inpatient rehabilitation facility qualification could become more difficult [...] - INFUSIONS:
Infusion Confusion Gone, Thanks To CMS
Transmittal states: Use G0350 once per session.
Providers who have been trying to squeeze their short-term [...] - PHYSICIANS:
Medicare Makes It Clear- Consults A 1-Doctor Affair
A consultation is a single physician's opinion, not a consensus.
Consults are hard work, and physicians [...] - PHYSICIANS:
Double-Digit Spending Growth A Bad Omen For 2006
What's behind the skyrocketing payments?
Physician spending rose a startling 15.2 percent in 2004 - the [...] - REIMBURSEMENT:
AMA Revving Up RVU Review Engine
E/M services the focus as AMA looks at reimbursement rates.
The AMA's Relative Value Update Committee [...] - HOSPITALS:
Hospital Organizations Say HSAs, HRAs Thriving
AHA and FAH say consumer-driven plan members will be equal.
Participants in so-called consumer-driven health plans [...] - DME:
Inhalation Drug Denials Leave Many Suppliers Gasping
... but CMS pledges to set DMERCs straight on G codes.
Durable medical equipment providers that [...] - PHARMACEUTICALS:
Enzi Treads Cautiously On Rx Importation
HELP will 'do something,' senator promises.
Sen. Mike Enzi (R-WY) said April 19 that his Health, [...] - ENFORCEMENT WATCH:
DOJ Circles Fraud Ring, Prison Possible For Leader
Massive kickback network offers no safety in numbers.
Just because a real physician wrote the prescription [...] - HOME HEALTH:
CMS Setting Sights On Medical Directors
Going overboard on number of directors raises a red flag.
The newest compliance hotspot for [...] - BILL WATCH
The following bills were introduced in the Senate: S. 911. A bill to amend title [...]
